Dichlororibofuranosylbenzimidazole [dichlororibofuranosylbenzimidazol]
topical
1
- Terms
-
5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazol
5,6-Dichloro-1-beta-ribofuranosylbenzimidazole
Dichlorobenzimidazole Riboside
DRB
Persistent link
https://www.medvik.cz/link/D004004
Definition
An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
- DUI
- D004004 MeSH Browser
- CUI
- M0006279
- CAS
- 1H-Benzimidazole, 5,6-dichloro-1-beta-D-ribofuranosyl-
- Previous indexing
- Nucleosides (1966-1970); Ribonucleosides (1971-1978); Benzimidazoles (1966-1978)
- History note
- 91(79); was see under RIBONUCLEOSIDES 1979-90
- Public note
- 91; was see under RIBONUCLEOSIDES 1979-90
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives 1
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records